Barrett's oesophagus

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
3 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Corticosteroid 1 substance
Monoclonal antibody (angiogenesis) 1 substance
Monoclonal antibody (chimeric) 1 substance
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Dr. Falk Pharma GmbH Commercial
    BUDESONIDE
    2023-507897-42-00 7 countries 2020 n=93
    Ended
  • University Medical Center Groningen Academic
    BEVACIZUMAB; CETUXIMAB
    2023-503801-12-00 1 country 2023 n=25
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Dr. Falk Pharma GmbH Commercial 1 Phase II 0
University Medical Center Groningen Academic 1 Phase II 0
New trials by year
2020
1
2023
1
← All indication landscapes